Skip to content

Comparability of the lateral versus the anterior approaches to block of the sciatic nerve, each in combination with a femoral nerve block.

Comparability of the lateral versus the anterior approaches to block of the sciatic nerve, each in combination with a femoral nerve block.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00018812
Enrollment
46
Registered
2019-10-09
Start date
2019-07-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M17.1 M17.0

Interventions

Group 1: Continous blockade of the femoral nerve (inguinal approach) in combination with a continous blockadde of the sciatic nerve (proximal-anterior approach) Group 2: Continous blockade of the femo

Sponsors

Asklepios Klinik LangenAbteilung für Anästhesie und perioperative Medizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult persons who are undergoing a total knee arthroplasty, able to give a Statement of intent, ASA-Class I-III

Exclusion criteria

Exclusion criteria: Intolerance to local anaesthetics, Patient refusal, skin infection at the site of needle insertion, not of full Age, ASA-Class IV-V, pregnancy or lactation, neurologic disease, insufficient knowledge of the german language, lack of cooperation, chronic pain Syndrom with opiops, BMI >35, coagulopathy, inability to give a Statement of intent

Design outcomes

Primary

MeasureTime frame
Quality of pain therapie. Patients interview about pain intensity (numeric ratin scale) and measurement of the cumulative oopioid consumption

Secondary

MeasureTime frame
Time needed to perform regional anaeshetic technique, muscular weakness, inflection and streching in knee joint

Countries

Germany

Contacts

Public ContactMichael Schöffner

Asklepios Klinik LangenAbteilung für Anästhesie und perioperative Medizin

m.schoeffner@asklepios.com0610391261405

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026